MIMEDX to Host First Quarter 2026 Operating and Financial Results Conference Call on April 29
Rhea-AI Summary
MiMedx (Nasdaq: MDXG) will report first quarter 2026 operating and financial results for the period ended March 31, 2026, after market close on Wednesday, April 29, 2026. The senior management team will host a webcast and conference call beginning at 4:30 p.m. Eastern Time that day.
According to the company, U.S. and international dial‑in numbers and a conference ID are provided, and a replay will be available on the company website for approximately 30 days following the event.
AI-generated analysis. Not financial advice.
Positive
- None.
Negative
- None.
News Market Reaction – MDXG
On the day this news was published, MDXG gained 4.53%, reflecting a moderate positive market reaction. Our momentum scanner triggered 9 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $22M to the company's valuation, bringing the market cap to $508.08M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Peer moves are mixed, with some biotechnology names up and others down. Only MAZE appeared in the momentum scanner, moving down while MDXG’s move appears stock-specific.
Previous Conferences,earnings Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Feb 17 | Earnings call schedule | Neutral | +0.8% | Set timing for Q4 and full-year 2025 results release and call. |
| Oct 15 | Earnings call schedule | Neutral | +2.0% | Announced Q3 2025 earnings release and conference call logistics. |
| Jul 16 | Earnings call schedule | Neutral | +6.0% | Scheduled Q2 2025 operating and financial results and webcast. |
| Apr 16 | Earnings call schedule | Neutral | -2.5% | Outlined Q1 2025 results release date and access details. |
| Feb 05 | Earnings call schedule | Neutral | -0.1% | Provided Q4 and full-year 2024 results timing and dial-in info. |
Earnings call scheduling headlines with this tag have typically led to modest single-digit moves, without a consistent positive or negative pattern.
Over the past year, MIMEDX has repeatedly issued conferences,earnings notices ahead of quarterly results, providing dates and 4:30 p.m. ET call details with 30-day replays. Prior such announcements on Feb 17, 2026, Oct 15, 2025, Jul 16, 2025, Apr 16, 2025, and Feb 5, 2025 produced generally modest share reactions, sometimes slightly positive and sometimes slightly negative, suggesting these scheduling releases function mainly as neutral informational updates.
Historical Comparison
In the past year, MIMEDX issued 5 similar conferences/earnings scheduling releases. The average move was about 1.23%, indicating these notices usually prompted only modest trading shifts.
The pattern reflects a regular cadence of quarterly earnings call announcements from early 2024 through early 2026, maintaining consistent timing and access formats for investors.
Market Pulse Summary
This announcement schedules MIMEDX’s Q1 2026 operating and financial results for April 29, 2026 at 4:30 p.m. ET, with a replay available for 30 days. It follows a series of similar quarterly conferences/earnings notices that historically produced modest share moves averaging about 1.23%. In light of recent restructuring steps and prior record 2025 performance, investors may focus on the upcoming call for updated demand trends and profitability metrics.
AI-generated analysis. Not financial advice.
MARIETTA, Ga., April 22, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the first quarter ended March 31, 2026 after the market close on Wednesday, April 29, 2026. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 4:30 p.m. Eastern Time on the same day.
The conference call can be accessed using the following information:
Webcast: Click here
U.S. Investors: 877-407-6184
International Investors: 201-389-0877
Conference ID: 13759618
A replay of the webcast will be available for approximately 30 days on the Company’s website at www.mimedx.com following the conclusion of the event.
About MIMEDX
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade and a half of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX provides a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.
Contact:
Matt Notarianni
Investor Relations
470-304-7291
mnotarianni@mimedx.com
